Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kahn

Showing results (521-530 of 666) with videos related to

Pageof 67
Sort By:
Springerplus|November 7, 2015
A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22Maureen Elizabeth Trudeau, Judith-Anne W Chapman, Baoqing Guo, et al.
The Journal of Infectious Diseases|December 12, 1997
The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trialS G Deeks, A Collier, J Lalezari, et al.
The Journal of Urology|March 20, 2012
Impact of nutritional factors on incident kidney stone formation: a report from the WHI OSMathew D Sorensen, Arnold J Kahn, Alex P Reiner, et al.
Vaccine|March 19, 2011
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasisJaya Chakravarty, Subodh Kumar, Sonali Trivedi, et al.
Vaccine|November 3, 2009
Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasisIván D Vélez, Katherine Gilchrist, Sofía Martínez, et al.
Vaccine|September 21, 2010
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasisAlejandro Llanos-Cuentas, Wessmark Calderón, María Cruz, et al.
The Journal of Infectious Diseases|October 1, 1996
Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working GroupsR W Coombs, S L Welles, C Hooper, et al.
Vaccine|August 7, 2010
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasisEvaldo Nascimento, Demetrios F Fernandes, Edva P Vieira, et al.
The Journal of Infectious Diseases|April 1, 1997
Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccinesS Zolla-Pazner, C Alving, R Belshe, et al.
Blood Cells, Molecules & Diseases|May 19, 2001
Erythrocyte membrane ATP binding cassette (ABC) proteins: MRP1 and CFTR as well as CD39 (ecto-apyrase) involved in RBC ATP transport and elevated blood plasma ATP of cystic fibrosisE H Abraham, K M Sterling, R J Kim, et al.
Pageof 67

Showing results (521-530 of 666) with videos related to

Sort By:
Pageof 67
Springerplus|November 7, 2015
A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22Maureen Elizabeth Trudeau, Judith-Anne W Chapman, Baoqing Guo, et al.
The Journal of Infectious Diseases|December 12, 1997
The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trialS G Deeks, A Collier, J Lalezari, et al.
The Journal of Urology|March 20, 2012
Impact of nutritional factors on incident kidney stone formation: a report from the WHI OSMathew D Sorensen, Arnold J Kahn, Alex P Reiner, et al.
Vaccine|March 19, 2011
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasisJaya Chakravarty, Subodh Kumar, Sonali Trivedi, et al.
Vaccine|November 3, 2009
Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasisIván D Vélez, Katherine Gilchrist, Sofía Martínez, et al.
Vaccine|September 21, 2010
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasisAlejandro Llanos-Cuentas, Wessmark Calderón, María Cruz, et al.
The Journal of Infectious Diseases|October 1, 1996
Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working GroupsR W Coombs, S L Welles, C Hooper, et al.
Vaccine|August 7, 2010
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasisEvaldo Nascimento, Demetrios F Fernandes, Edva P Vieira, et al.
The Journal of Infectious Diseases|April 1, 1997
Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccinesS Zolla-Pazner, C Alving, R Belshe, et al.
Blood Cells, Molecules & Diseases|May 19, 2001
Erythrocyte membrane ATP binding cassette (ABC) proteins: MRP1 and CFTR as well as CD39 (ecto-apyrase) involved in RBC ATP transport and elevated blood plasma ATP of cystic fibrosisE H Abraham, K M Sterling, R J Kim, et al.
Pageof 67